Significance of Perianal Lesion in Pediatric Crohn Disease

Won Seok Jin1, Ji Hyoung Park1, Kyung In Lim1

  • 1Department of Pediatrics, Gachon University Gil Medical Center, Incheon, Korea.

Insights

Pediatric Crohn disease (CD) in Korea frequently involves perianal lesions, often appearing before gastrointestinal symptoms. Early suspicion of CD is crucial in children presenting with perianal issues.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Epidemiology

Background:

  • Increasing incidence of pediatric Crohn disease (CD) in Korea.
  • Limited data on perianal lesion characteristics in pediatric CD.
  • Need for understanding the presentation of pediatric CD in the Korean population.

Purpose of the Study:

  • Investigate the characteristics of perianal lesions in pediatric CD patients in Korea.
  • Determine the prevalence of perianal lesions, including perforating types.
  • Analyze the relationship between perianal lesions and disease duration/symptom onset.

Main Methods:

  • Retrospective review of medical records for children (age ≤18 years) with confirmed CD.
  • Classification of patients into groups based on the presence/absence of perianal lesions (including skin tags).
  • Further analysis based on the presence/absence of perianal perforating lesions.

Main Results:

  • High prevalence of perianal lesions (78.3%) and perforating lesions (42.0%) in pediatric CD.
  • Longer duration of chief complaints in pediatric CD with any perianal lesions.
  • Perianal symptoms preceded gastrointestinal symptoms in 44.8% of patients with perforating perianal lesions.

Conclusions:

  • Crohn disease should be suspected in children with perianal lesions.
  • Consideration of CD is important even when gastrointestinal symptoms are initially absent.
  • Highlights the significance of perianal manifestations in early pediatric CD diagnosis.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
518
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
550
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
573
Statistical Significance01:50

Statistical Significance

Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
22.0K
Significance of Center of Mass01:12

Significance of Center of Mass

The center of mass of an object is defined as the mass-weighted average position of all the particles that comprise the object. The significance of the center of mass of an object can be seen by looking at its dynamics. The time derivative of the center of mass gives its velocity, assuming that the object's mass remains constant over time. Furthermore, the total linear momentum of an object can be seen as the linear momentum of a single particle of the object's total mass moving with...
7.7K